Sierra Summit Advisors’s Apellis Pharmaceuticals APLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,714
Closed -$222K 149
2023
Q4
$222K Buy
+3,714
New +$222K 0.06% 174